Clinical Trials
127 trialsSBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
Fudan University
POSTILV
Radiation Therapy Oncology Group
Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)
Fudan University
Dose-staged Gamma Knife Radiosurgery Versus Microsurgical Resection
Medical University of Vienna
Notable-HCC
Shandong Cancer Hospital and Institute
Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC
Sun Yat-sen University
HALT
Institute of Cancer Research, United Kingdom
Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
Sheba Medical Center
K-SAB
Karolinska University Hospital
TREATMENT
Oslo University Hospital
SRSvsWBRT
Post Graduate Institute of Medical Education and Research, Chandigarh
IMMUNOs-SBRT
Centre Georges Francois Leclerc
Combining ICI With SBRT or HypoFrx-RT for ES NSCLC
Xuanwu Hospital, Beijing
SAFO
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
First Affiliated Hospital of Guangxi Medical University
Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)
Elisabeth-TweeSteden Ziekenhuis
BRPCNCC-1
Changhai Hospital
SBRT Plus vNKT for Pancreatic Cancer
Changhai Hospital
TaRRGET
Prof. Franciszek Lukaszczyk Memorial Oncology Center
SCARCE
Peking University Third Hospital
Re-irradiation With Stereotactic Body Radiotherapy for Relapsed Pancreatic Cancer
Changhai Hospital
SM-SBRT
Shanghai Zhongshan Hospital
Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs
Shanghai Cancer Hospital, China
Metabolomic Study for Localized Prostate Cancer
Georgetown University
PR-PROS
Georgetown University
Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
First Affiliated Hospital of Zhejiang University
WHOBI-STER
Mediterranean Institute of Oncology
COLLISION-XL
Amsterdam UMC, location VUmc
Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery
University of Southern California
Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer
University Hospital Ostrava
FIBROPANC-1
Erasmus Medical Center
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
California Pacific Medical Center Research Institute
Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence
Huashan Hospital
SBRT Versus Conventional Fractionated Radiotherapy for Vertebral Metastases
Wuhan University
5STAR-PC
Sunnybrook Health Sciences Centre
Tislelizumab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With Advanced CRC
Huazhong University of Science and Technology
Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors
Instituto de investigación e innovación biomédica de Cádiz
IMCORT-2
Sichuan Cancer Hospital and Research Institute
Noelia
Clinica Universidad de Navarra, Universidad de Navarra
A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer
West China Hospital
Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma
Centre Francois Baclesse, Luxembourg
CKBrainMeta
Centre Francois Baclesse, Luxembourg
Study on SBRT for Inoperable Lung and Liver Oligometastases From Breast Cancer
Istituto Clinico Humanitas
SOFT
Herlev Hospital
Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer
Fudan University
CROP
Sunnybrook Health Sciences Centre
HiSparCK
Ottawa Hospital Research Institute
BoMB
Campus Bio-Medico University